# Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

> **NCT02022293** · PHASE2 · SUSPENDED · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 324 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Radiation Therapy Complication

## Interventions

- **DRUG:** Atorvastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02022293
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-01
- **Target enrollment:** 324 (ESTIMATED)
- **Why stopped:** Enrollment target could not be achieved.
- **Last updated:** 2017-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022293, "Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02022293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*